Central Admixture Pharmacy Services, Inc. 2023-09-06 Health serious FDA
Health · FDA · Recall #FDA-D-1129-2023
EPINEPHrine, 2 mg added to dextrose 5% 250mL, Concentration = 8 mcg/mL, IV Bag, Rx Only,… Recall
Issued September 6, 2023 · Central Admixture Pharmacy Services, Inc.
In September 2023, Central Admixture Pharmacy Services, Inc. recalled the EPINEPHrine, 2 mg added to dextrose 5% 250mL, Concentration = 8 mcg/mL, IV Bag, Rx Only,…, a serious health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
What you should do
- 1 Stop using EPINEPHrine, 2 mg added to dextrose 5% 250mL, Concentration = 8 mcg/mL, IV Bag, Rx Only,… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Central Admixture Pharmacy Services, Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Central Admixture Pharmacy Services, Inc.
- Category
- Health
- Recall date
- September 6, 2023
- Units affected
- Not reported
- Sold at
- Nationwide in the USA
- Recall number
- FDA-D-1129-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- Central Admixture Pharmacy Services, Inc. has 100 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.